Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hinge Health (HNGE) Shares Outstanding (Diluted Average) (2023 - 2025)

Hinge Health (HNGE) has disclosed Shares Outstanding (Diluted Average) for 3 consecutive years, with $54.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 302.54% to $54.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $54.6 million through Dec 2025, up 302.54% year-over-year, with the annual reading at $54.6 million for FY2025, 302.54% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $54.6 million in Q4 2025 for Hinge Health, up from $46.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $54.6 million in Q4 2025 to a low of $13.0 million in Q4 2023.
  • Historically, Shares Outstanding (Diluted Average) has averaged $28.8 million across 3 years, with a median of $16.6 million in 2024.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 4.16% in 2024 and later skyrocketed 302.54% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $13.0 million in 2023, then increased by 4.16% to $13.6 million in 2024, then surged by 302.54% to $54.6 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for HNGE at $54.6 million in Q4 2025, $46.2 million in Q3 2025, and $13.6 million in Q4 2024.